-
Je něco špatně v tomto záznamu ?
Epigenetics of multiple myeloma after treatment with cytostatics and gamma radiation
J. Krejčí, A. Harničarová, D. Štreitová, R. Hájek, L. Pour, S. Kozubek, E. Bártová
Jazyk angličtina Země Velká Británie
Typ dokumentu práce podpořená grantem
NLK
ScienceDirect (archiv)
od 1993-01-01 do 2009-12-31
- MeSH
- antitumorózní látky terapeutické užití MeSH
- apoptóza MeSH
- chromatinová imunoprecipitace MeSH
- cyklin D1 genetika MeSH
- DNA primery MeSH
- epigeneze genetická MeSH
- geny myc MeSH
- kombinovaná terapie MeSH
- lidé MeSH
- mnohočetný myelom farmakoterapie genetika patologie radioterapie MeSH
- polymerázová řetězová reakce MeSH
- proliferace buněk MeSH
- průtoková cytometrie MeSH
- sekvence nukleotidů MeSH
- záření gama terapeutické užití MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- práce podpořená grantem MeSH
Genetic and epigenetic changes in multiple myeloma (MM) correlate with the stage of the disease. Therefore, we investigated how cytostatics and gamma radiation influence MM-associated histone modifications. ChIP-PCR and ChIP-on-chip technologies were used to quantify H3K9 acetylation and H3K9 dimethylation at select loci in MM patients, lymphoblastoid ARH-77, and myeloma MOLP-8 cells. Genome-wide analysis revealed that the cytostatic, melphalan, increased H3K9 acetylation at multiple gene promoters in ARH-77 cells. Melphalan and gamma radiation also influenced histone modification of prognostically important c-myc and CCND1 genes in ARH-77 and MOLP-8 cells. Moreover, H3K9 acetylation at c-myc and CCND1 promoters was increased in individual MM patients after melphalan treatment. Western blotting revealed that these effects were accompanied by changes in c-MYC and cyclin D1 protein levels. Taken together, we showed that cytostatics significantly alter histone modification of tumor-related genes which is indispensable for understanding cancer therapies.
- 000
- 02813naa 2200493 a 4500
- 001
- bmc11016617
- 003
- CZ-PrNML
- 005
- 20120307155828.0
- 008
- 110628s2009 xxk e eng||
- 009
- AR
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Krejčí, Jana $7 xx0128638
- 245 10
- $a Epigenetics of multiple myeloma after treatment with cytostatics and gamma radiation / $c J. Krejčí, A. Harničarová, D. Štreitová, R. Hájek, L. Pour, S. Kozubek, E. Bártová
- 314 __
- $a Institute of Biophysics, Academy of Sciences of the Czech Republic, 612 65 Brno, Czech Republic.
- 520 9_
- $a Genetic and epigenetic changes in multiple myeloma (MM) correlate with the stage of the disease. Therefore, we investigated how cytostatics and gamma radiation influence MM-associated histone modifications. ChIP-PCR and ChIP-on-chip technologies were used to quantify H3K9 acetylation and H3K9 dimethylation at select loci in MM patients, lymphoblastoid ARH-77, and myeloma MOLP-8 cells. Genome-wide analysis revealed that the cytostatic, melphalan, increased H3K9 acetylation at multiple gene promoters in ARH-77 cells. Melphalan and gamma radiation also influenced histone modification of prognostically important c-myc and CCND1 genes in ARH-77 and MOLP-8 cells. Moreover, H3K9 acetylation at c-myc and CCND1 promoters was increased in individual MM patients after melphalan treatment. Western blotting revealed that these effects were accompanied by changes in c-MYC and cyclin D1 protein levels. Taken together, we showed that cytostatics significantly alter histone modification of tumor-related genes which is indispensable for understanding cancer therapies.
- 590 __
- $a bohemika - dle Pubmed
- 650 _2
- $a antitumorózní látky $x terapeutické užití $7 D000970
- 650 _2
- $a apoptóza $7 D017209
- 650 _2
- $a sekvence nukleotidů $7 D001483
- 650 _2
- $a proliferace buněk $7 D049109
- 650 _2
- $a chromatinová imunoprecipitace $7 D047369
- 650 _2
- $a kombinovaná terapie $7 D003131
- 650 _2
- $a cyklin D1 $x genetika $7 D019938
- 650 _2
- $a DNA primery $7 D017931
- 650 _2
- $a epigeneze genetická $7 D044127
- 650 _2
- $a průtoková cytometrie $7 D005434
- 650 _2
- $a záření gama $x terapeutické užití $7 D005720
- 650 _2
- $a geny myc $7 D016259
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mnohočetný myelom $x farmakoterapie $x genetika $x patologie $x radioterapie $7 D009101
- 650 _2
- $a polymerázová řetězová reakce $7 D016133
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Harničarová, Andrea. $7 mub2011654526
- 700 1_
- $a Štreitová, Denisa. $7 xx0044358
- 700 1_
- $a Hájek, Roman, $d 1964- $7 nlk20000083645
- 700 1_
- $a Pour, Luděk $7 xx0102556
- 700 1_
- $a Kozubek, Stanislav, $d 1953- $7 ola2003204933
- 700 1_
- $a Bártová, Eva. $7 xx0028314
- 773 0_
- $t Leukemia Research $w MED00003141 $g Roč. 33, č. 11 (2009), s. 1490-1498
- 910 __
- $a ABA008 $b x $y 2
- 990 __
- $a 20110720115251 $b ABA008
- 991 __
- $a 20120307155838 $b ABA008
- 999 __
- $a ok $b bmc $g 864027 $s 726398
- BAS __
- $a 3
- BMC __
- $a 2009 $x MED00003141 $b 33 $c 11 $d 1490-1498 $m Leukemia research $n Leuk Res
- LZP __
- $a 2011-3B09/BBjvme